Ami Organics
The shares of Ami Organics listed on the Indian stock exchanges today making a stellar debut on the NSE at Rs 910, up 49.18% from its issue price of Rs 610. Ami Organics’ stock began trading at Rs 902 on the BSE, up 47.87%.
Ami Organics Rs 570-crore IPO was open for subscription from September 1st to September 3rd. According to official data, Ami Organics IPO got bids for over 42.22 crore shares out of a total issue size of over 65.42 lakh shares.
The Ami Organics IPO consists of a fresh issue of shares for Rs 200 crore and an offer for existing shareholders to sell up to 60,59,600 equity shares.
The proceeds from the new offering will be used to settle certain debts and meet working capital requirements.
The Ami Organics IPO consists of a fresh issue of shares for Rs 200 crore. The proceeds from the new offering will be used to settle certain debts and meet working capital requirements.
Ami Organics Limited, based in Gujarat, is a research-driven manufacturer of speciality chemicals with a wide range of end uses, with a particular focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredients (APIs) and New Chemical Entities (NCEs), as well as key starting materials for agrochemical and fine chemicals.
Vijaya Diagnostic Centre
Vijaya Diagnostic Centre, a Hyderabad-based diagnostic chain operator, debuted on Dalal Street at a 2% premium to its initial public offering price of Rs 531 per share.
The stock began 1.69 per cent higher at Rs 540 on the National Stock Exchange, after listing at Rs 542.30 on the BSE, 2.13 per cent higher than the issue price.
The public offering of Vijaya Diagnostics was 4.54 times subscribed, compared to 64.54 times for speciality chemical manufacturer Ami Organics. From September 1st to 3rd, both issues were available for subscription.
Qualified institutional purchasers backed Vijaya Diagnostics‘ public offering, bidding for 13.07 times the number of shares allotted for them.
The component for non-institutional investors was 1.32 times subscribed, while the amount for individual investors was 1.09 times subscribed. Employees competed for 98 per cent of the available space.
The Rs 1,895 crore public offering by promoter S Surendranath Reddy and investors Karakoram and Kedaara Capital Alternative Investment Fund – Kedaara Capital AIF 1 was purely an offer for sale.
Because it has a regional footprint (Telangana and Andhra Pradesh) it may suffer profit pressure due to rising healthcare expenses, brokerages had varied perspectives on the subject.
It does, however, have a well-integrated company plan with excellent financial results.
